The IHC ER-PR test, or Immunohistochemistry Estrogen Receptor-Progesterone Receptor test, is a specialized diagnostic procedure designed to evaluate the presence of estrogen and progesterone receptors in breast cancer cells. This test is crucial for determining the hormone responsiveness of breast cancer, which in turn guides the treatment plan, including decisions regarding hormone therapy. By identifying the hormone receptor status, oncologists can tailor treatment strategies that are more likely to be effective for the individual patient.

Conducted at DNA Labs UAE, a reputable facility known for its advanced diagnostic services, the IHC ER-PR test involves the examination of tissue samples under a microscope after they have been treated with specific antibodies that react to estrogen and progesterone receptors. The presence or absence of these receptors provides valuable insights into the cancer’s characteristics and potential behavior.

The cost of the IHC ER-PR test at DNA Labs UAE is 600 AED. This price reflects the sophisticated nature of the test and the invaluable information it provides, which plays a pivotal role in the management and treatment of breast cancer. Patients and healthcare providers considering this test should be aware of the importance of its results in the broader context of breast cancer care and treatment planning.